Stromectol

(Ivermectin)

ApprovedSmall molecule

CCidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

Ivermectin is used to treat parasitic infections caused by certain worms and lice, both in humans and animals. It works by paralyzing and killing the parasites so your body can eliminate them.[2] Stromectol is currently approved and in use across 23 indications[4].[1]

Stromectol is one of 348 small molecule programs targeting Loiasis. It is currently in Approved.

Indications

135

Total Trials

Active Trials

347

Competitors

FDA Applications

NDA/BLA/ANDA regulatory filings

Patents

Pipeline

Status by Indication[4][1]

Indication

LoiasisActive, not recruiting

Dengue Hemorrhagic FeverApproved

LeishmaniasisApproved

Lice InfestationActive, not recruiting

OnchocerciasisActive, not recruiting

Atopic EczemaApproved

AnosmiaApproved

RosaceaActive, not recruiting

AcneApproved

Severe Acute Respiratory SyndromeActive, not recruiting

LoiasisApproved

Active, not recruiting

Dengue Hemorrhagic FeverApproved

Approved

LeishmaniasisApproved

Approved

Lice InfestationPhase 3

Active, not recruiting

OnchocerciasisApproved

Active, not recruiting

Atopic EczemaApproved

Approved

AnosmiaApproved

Approved

RosaceaPhase 3

Active, not recruiting

AcneApproved

Approved

Severe Acute Respiratory SyndromePhase 3

Active, not recruiting

Showing 10 of 23 indications

Competition

Competitive Landscape

2828 competitors in Breast Cancer

#DrugCompanyPhaseTrials

Stromectol

CCidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

Approved

1 2

Trodelvy

Gilead

Preclinical

37 3

Zinecard

CChildren's Oncology Group

Preclinical

2 4

Spravato

WWim Janssens

Preclinical

2 5

Nubain

AAultman Health Foundation

Preclinical

1 6

Feraheme

AAzurity Pharmaceuticals

Preclinical

1 7

Systemic Therapy

Bristol-Myers Squibb

Preclinical

1 8

Beta Blocker

WWeill Medical College of Cornell University

Preclinical

1 9

Perflutren Lipid Microcpheres

TThomas Jefferson University

Preclinical

2 10

Lipegfilgrastim

Merck & Co.

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q4 2026

Phase 1/2Recruiting

Breast Cancer

NCT05318469

Phase 2Active, not recruiting

Onchocerciasis

NCT05180461

Q1 2027

Phase 2Recruiting

COVID-19

NCT05041907

Q2 2027

Phase 1Not yet recruiting

Cutaneous Warts

NCT07396714

Q3 2027

Phase 1Active, not recruiting

Rosacea

NCT04108897

Clinical

Trials by Indication[1]

COVID-1955 trials

Effectiveness of Ivermectin in SARS-CoV-2/COVID-19 Patients

Completed·FFMH College of Medicine and Dentistry·Phase 4·NCT04739410·50 enrolled

ACTIV-6: COVID-19 Study of Repurposed Medications - Arm D (Ivermectin 600)

Completed·—·Phase 3·NCT05894538·1,459 enrolled

Efficacy and Safety of Ivermectin for Treatment and Prophylaxis of COVID-19 Pandemic

Completed·—·N/A·NCT04668469·600 enrolled

Show 52 more trials

Prophylaxis for COVID-19: Ivermectin in Close Contacts of COVID-19 Cases (IVERNEX-TUC)

Completed·MMinistry of Public Health, Argentina·Phase 2/3·NCT04894721·172 enrolled

ACTIV-6: COVID-19 Study of Repurposed Medications - Arm A (Ivermectin 400)

Completed·—·Phase 3·NCT05736861·1,800 enrolled

Ivermectin as a Novel Therapy in COVID-19 Treatment

Completed·TTanta University·Phase 2/3·NCT04403555·164 enrolled

Ivermectin in Adults With Severe COVID-19.

Terminated·—·Phase 2·NCT04602507·75 enrolled

Ivermectin-Azithromycin-Cholecalciferol (IvAzCol) Combination Therapy for COVID-19

Completed·IInstituto de Seguridad y Servicios Sociales de los Trabajadores del Estado·N/A·NCT04399746·30 enrolled

Effectiveness and Safety of Ivermectin for the Prevention of Covid-19 Infection in Colombian Health Personnel

Unknown status·JJaveriana University·Phase 3·NCT04527211·550 enrolled

Ivermectin for Severe COVID-19 Management

Completed·—·Phase 3·NCT04646109·66 enrolled

Hydroxychloroquine and Ivermectin for the Treatment of COVID-19 Infection

Completed·—·Phase 3·NCT04391127·108 enrolled

Ivermectin Reproposing for Mild Stage COVID-19 Outpatients

Completed·MMinistry of Public Health, Argentina·Phase 1/2·NCT04784481·254 enrolled

Ivermectin for Post Exposure Prophylaxis of Covid-19

Terminated·—·Phase 3·NCT05231603·50 enrolled

The Efficacy of Ivermectin in Larger Doses in COVID-19 Treatment

Recruiting·TTanta University·Phase 2/3·NCT04351347·300 enrolled

COVidIVERmectin: Ivermectin for Treatment of Covid-19

Terminated·IIRCCS Sacro Cuore Don Calabria di Negrar·Phase 2·NCT04438850·93 enrolled

Sars-CoV-2/COVID-19 Ivermectin Navarra-ISGlobal Trial

Completed·—·Phase 2·NCT04390022·24 enrolled

Evaluation of the Impact of the Administration of Single Dose of Ivermectin in the Early Phase of COVID-19

Unknown status·—·Phase 3·NCT05040724·200 enrolled

Ivermectin Role in Covid-19 Clinical Trial

Completed·—·Phase 4·NCT04746365·300 enrolled

Observational Study on the Use of Ivermectin as an Outpatient Treatment Option for COVID-19

Unknown status·PPatrick Robinson··NCT05045937·1,000 enrolled

Remdesivir- Ivermectin Combination Therapy in Severe Covid-19

Unknown status·—·Phase 4·NCT04944082·60 enrolled

A Study to Compare the Efficacy and Safety of Different Doses of Ivermectin for COVID-19

Terminated·—·Phase 2·NCT04431466·32 enrolled

Efficacy of Ivermectin in COVID-19

Completed·—·Phase 1/2·NCT05076253·72 enrolled

Ivermectin in Treatment of COVID-19

Unknown status·ZZagazig University·Phase 2/3·NCT04445311·100 enrolled

Worldwide Trends on COVID-19 Research After the Declaration of COVID-19 Pandemic

Unknown status·QQassim University··NCT04460547·200 enrolled

Trial of Combination Therapy to Treat COVID-19 Infection

Completed·PProgenaBiome·Phase 1·NCT04482686·31 enrolled

Comparative Study of Hydroxychloroquine and Ivermectin in COVID-19 Prophylaxis

Unknown status·NNucleo De Pesquisa E Desenvolvimento De Medicamentos Da Universidade Federal Do Ceara·N/A·NCT04384458·400 enrolled

Ivermectin to Prevent Hospitalizations in COVID-19

Completed·IInstituto de Cardiología de Corrientes·Phase 2/3·NCT04529525·501 enrolled

Novel Agents for Treatment of High-risk COVID-19 Positive Patients

Terminated·SSusanne Arnold·Phase 2·NCT04374019·13 enrolled

ACTIV-6: COVID-19 Study of Repurposed Medications

Completed·—·Phase 3·NCT04885530·10,956 enrolled

Ivermectin to Prevent SARS-CoV-2 (COVID-19) Hospitalisation in Subjects Over 50

Terminated·IInsud Pharma·Phase 3·NCT05993143·249 enrolled

Montelukast - a Treatment Choice for COVID-19

Completed·UUniversity of Sargodha··NCT04714515·150 enrolled

Randomized Phase IIA Clinical Trial to Evaluate the Efficacy of Ivermectin to Obtain Negative PCR Results in Patients With Early Phase COVID-19

Completed·UUniversidad Peruana Cayetano Heredia·Phase 2·NCT04635943·186 enrolled

Comparative Therapeutic Efficacy and Safety of Different Antiviral and Anti Inflammatory Drugs in COVID-19 Patients.

Unknown status·OOctober 6 University·Phase 4·NCT04779047·150 enrolled

Prophylaxis of COVID-19 Disease With Ivermectin in COVID-19 Contact Persons [German: Prophylaxe Der COVID-19-Erkrankung Mit Ivermectin Bei COVID-19 Kontaktpersonen]

Unknown status·IInfectopharm Arzneimittel GmbH·Phase 3·NCT05060666·412 enrolled

COVID-OUT: Early Outpatient Treatment for SARS-CoV-2 Infection (COVID-19)

Completed·UUniversity of Minnesota·Phase 3·NCT04510194·1,323 enrolled

The Zambia Ivermectin Trial for the Treatment and Prevention of COVID-19

Withdrawn·CCentre for Infectious Disease Research in Zambia·Phase 4·NCT04891250

Exploratory Ph I Trial of the Active IMP in Healthy Volunteers in Relation to COVID-19

Completed·MMedinCell S.A·Phase 1·NCT04632706·24 enrolled

Finding Treatments for COVID-19: A Trial of Antiviral Pharmacodynamics in Early Symptomatic COVID-19 (PLATCOV)

Recruiting·UUniversity of Oxford·Phase 2·NCT05041907·3,800 enrolled

Early Treatment With Ivermectin and LosarTAN for Cancer Patients With COVID-19 Infection

Terminated·IInstituto do Cancer do Estado de São Paulo·Phase 2·NCT04447235·77 enrolled

Prophylactic Ivermectin in COVID-19 Contacts

Completed·ZZagazig University·Phase 2/3·NCT04422561·340 enrolled

Effectiveness of Ivermectin as add-on Therapy in COVID-19 Management

Completed·UUniversity of Baghdad·Phase 1·NCT04343092·16 enrolled

An Outpatient Clinical Trial Using Ivermectin and Doxycycline in COVID-19 Positive Patients at High Risk to Prevent COVID-19 Related Hospitalization

Unknown status·UUnknown Sponsor·Phase 4·NCT04729140·150 enrolled

Ivermectin Versus Standard Treatment in Mild COVID-19

Unknown status·—·Phase 3·NCT04937569·1,644 enrolled

Ivermectin With Favipiravir in Mild-to-moderate COVID-19 Patients

Unknown status·MMahidol University·Phase 2·NCT05155527·200 enrolled

Role of Ivermectin and Colchicine in Treatment of COVID-19: Randomized Controlled Clinical Trial

Completed·—·N/A·NCT05930002·120 enrolled

Efficacy of Ivermectin in Outpatients With Non-severe COVID-19

Unknown status·UUniversidad Nacional de Asunción·Phase 3·NCT04834115·400 enrolled

A Study to Evaluate the Efficacy and Safety of Ivermectin in COVID-19 Prevention

Completed·MMedinCell S.A·Phase 2·NCT05305560·400 enrolled

Inhaled Ivermectin and COVID-19

Unknown status·MMansoura University·Phase 3·NCT04681053·80 enrolled

Efficacy of Subcutaneous Ivermectin With or Without Zinc in COVID-19 Patients

Unknown status·SSohaib Ashraf·Phase 1/2·NCT04472585·180 enrolled

Ivermectin Nasal Drops in Post COVID-19 Parosmia

Unknown status·MMenoufia University·Phase 2·NCT05269030·60 enrolled

Ivermectin vs. Placebo for the Treatment of Patients With Mild to Moderate COVID-19

Unknown status·SSheba Medical Center·N/A·NCT04429711·100 enrolled

Efficacy of Ivermectin in Adult Patients With Early Stages of COVID-19 (EPIC Trial)

Completed·CCentro de Estudios en Infectogía Pediatrica·Phase 2/3·NCT04405843·476 enrolled

Study in COvid-19 Patients With iveRmectin (CORVETTE-01)

Unknown status·KKitasato University·Phase 2·NCT04703205·214 enrolled

Efficacy of Ivermectin in COVID-19

Unknown status·—·N/A·NCT04392713·100 enrolled

Ivermectin Nasal Spray for COVID19 Patients

Unknown status·TTanta University·Phase 2·NCT04510233·60 enrolled

Treatment11 trials

Treatment of Strongyloides Infection

Terminated·—·Phase 3·NCT03605758·51 enrolled

Ivermectin in the Treatment of Head Lice

Completed·JJohnson & Johnson Consumer and Personal Products Worldwide·Phase 3·NCT00819520·812 enrolled

Comparison of Oral Ivermectin and Permethrin 5% Lotion in Treatment of Pediculosis Capitis

Completed·—·Phase 1·NCT05643820·60 enrolled

Show 8 more trials

Ivermectin In Treatment of COVID 19 Patients

Unknown status·MMinistry of Health and Population, Egypt·N/A·NCT04425707·100 enrolled

Impact of Community Scabies Treatment on Head Lice Prevalence in the Solomon Islands

Completed·LLondon School of Hygiene and Tropical Medicine·Phase 3·NCT03236168·118 enrolled

Treatment of Pediculosis (Head Lice) in Senegal

Completed·IInstitut de Recherche pour le Developpement·N/A·NCT03578679·450 enrolled

Treatment of Ocular Demodex Infestation With Topical Ivermectin Cream 1%

Unknown status·HHelm Vision Group·Phase 1·NCT05213585·20 enrolled

Repurposing Ivermectin for PKDL Treatment

Completed·IInternational Centre for Diarrhoeal Disease Research, Bangladesh·Phase 1·NCT06251739·30 enrolled

Comparative Study Between Topical Permethrin 5% and Oral Ivermectin for the Treatment of Scabies

Completed·—·Phase 1·NCT05362513·100 enrolled

Ivermectin Repurposed for the Treatment of PKDL

Completed·IInternational Centre for Diarrhoeal Disease Research, Bangladesh·Phase 1·NCT07286604·10 enrolled

Comparison of Permethrin and Ivermectin in Children Greater Than 6 Yrs Age for Treatment of Scabies

Not yet recruiting·—·Phase 2·NCT06896929·90 enrolled

Malaria7 trials

Repeat Ivermectin Mass Drug Administrations for MALaria Control II

Completed·BBrian Foy·Phase 3·NCT03967054·4,124 enrolled

Repeat Ivermectin Mass Drug Administrations for Control of Malaria: a Pilot Safety and Efficacy Study

Completed·—·Phase 2/3·NCT02509481·2,712 enrolled

Adjunctive Ivermectin Mass Drug Administration for Malaria Control

Unknown status·LLondon School of Hygiene and Tropical Medicine·Phase 3·NCT04844905·24,000 enrolled

Show 4 more trials

Ivermectin-artemisinin Combination Therapy for Eradication of Malaria

Unknown status·MMakerere University·Phase 4·NCT05605925·138 enrolled

Efficacy and Safety of High-dose Ivermectin for Reducing Malaria Transmission: A Dose Finding Study

Completed·LLiverpool School of Tropical Medicine·Phase 2·NCT02511353·141 enrolled

Mass Drug Administration of Ivermectin and Dihydroartemisinin-piperaquine as an Additional Intervention for Malaria Elimination

Completed·LLondon School of Hygiene and Tropical Medicine·Phase 3·NCT03576313·4,939 enrolled

Broad One Health Endectocide-based Malaria Intervention in Africa (BOHEMIA)

Completed·BBarcelona Institute for Global Health·Phase 3·NCT04966702·48,145 enrolled

Onchocerciasis7 trials

Safety of a Single Dose of Moxidectin Compared With Ivermectin in Individuals Living in Onchocerciasis Endemic Areas and in Individuals Living in Onchocerciasis Endemic Areas With High Levels of Lymphatic Filariasis Co-endemicity Receiving Concomitant Albendazole

Completed·MMedicines Development for Global Health·Phase 3·NCT04311671·12,979 enrolled

Ivermectin Treatment of Persons With Onchocerciasis-associated Epilepsy

Completed·UUniversiteit Antwerpen·Phase 4·NCT03852303·197 enrolled

Moxidectin Versus Ivermectin as Mass Drug Administration for the Control of Onchocerciasis and Other Neglected Tropical Diseases

Recruiting·KKirby Institute·Phase 4·NCT07145736·52,000 enrolled

Show 4 more trials

Ivermectin Treatment in Patients With Onchocerciasis-associated Epilepsy

Completed·RRobert Colebunders·Phase 4·NCT03052998·91 enrolled

Safety and Efficacy of Annual or Biannual Doses of Moxidectin or Ivermectin for Onchocerciasis

Active, not recruiting·MMedicines Development for Global Health·Phase 3·NCT03876262·323 enrolled

IVM Alone vs ALB + IVM Against Onchocerciasis

Completed·UUniversity Hospitals Cleveland Medical Center·Phase 3·NCT03238131·272 enrolled

Emodepside Phase II Trial for Treatment of Onchocerciasis

Active, not recruiting·DDrugs for Neglected Diseases·Phase 2·NCT05180461·578 enrolled

Rosacea4 trials

Evaluation of the Inhibitory Effects of Topical Ivermectin on Markers of Rosacea Specific Inflammation.

Completed·UUniversity of California, San Diego·Phase 1/2·NCT02806414·25 enrolled

Rosacea and Ivermectin

Completed·WWake Forest University Health Sciences·Phase 2·NCT04275999·30 enrolled

Comparative Safety and Efficacy of Two Treatments in the Treatment of Inflammatory Lesions of Rosacea

Completed·PPadagis LLC·Phase 3·NCT02795117·486 enrolled

Show 1 more trial

Analysis of the Microbiome in Rosacea

Active, not recruiting·JJohns Hopkins University·Phase 1·NCT04108897·150 enrolled

37 more indications

Efficacy and Safety3 trials

Efficacy and Safety of MOX/ALB vs. IVM/ALB Co-administration

Completed·JJennifer Keiser·Phase 2/3·NCT04700423·536 enrolled

Efficacy and Safety of MOX/ALB Co-administration

Completed·JJennifer Keiser·Phase 3·NCT04726969·255 enrolled

Efficacy and Safety of Moxidectin Versus Ivermectin Against Strongyloides Stercoralis

Completed·JJennifer Keiser·Phase 3·NCT04848688·332 enrolled

Children2 trials

Oral Ivermectin Versus Topical Permethrin to Treat Scabies in Children and Adults

Completed·UUniversity Hospital, Bordeaux·Phase 3·NCT02407782·1,092 enrolled

Ivermectin Safety in Small Children

Completed·UUniversity of Oxford·Phase 2·NCT04332068·240 enrolled

Loiasis2 trials

Loiasis Cross-reactive Antigenemia and Treatment-related Adverse Events

Completed·WWashington University School of Medicine·Phase 4·NCT05085665·41 enrolled

Post-treatment Effects of Ivermectin (IVM) or Diethylcarbamazine (DEC) in Loiasis

Completed·NNational Institute of Allergy and Infectious Diseases (NIAID)·Phase 4·NCT01593722·155 enrolled

Lymphatic Filariasis2 trials

Safety Study of Combined Azithromycin, Ivermectin and Albendazole for Trachoma and Lymphatic Filariasis

Withdrawn·EEmory University·Phase 4·NCT01903057

Lymphatic Filariasis (LF) in Ivory Coast

Completed·UUniversity Hospitals Cleveland Medical Center·N/A·NCT02974049·189 enrolled

Efficacy2 trials

Efficacy, Safety, and PK of Ascending Dosages of Moxidectin Versus Ivermectin Against Strongyloides Stercoralis

Completed·JJennifer Keiser·Phase 2/3·NCT04056325·617 enrolled

Efficacy Study Between Two Different Dosages of an Antiparasitic in Patients With Crusted Scabies

Completed·AAssistance Publique - Hôpitaux de Paris·Phase 3·NCT02841215·133 enrolled

Strongyloidiasis2 trials

Ivermectin Versus Albendazole for Chronic Strongyloidiasis

Completed·MMahidol University·Phase 3·NCT00765024·90 enrolled

Multiple Versus Single Dose of Ivermectin for the Treatment of Strongyloidiasis

Completed·CCentro per le Malattie Tropicali·Phase 3·NCT01570504·312 enrolled

Infection2 trials

Study Comparing Moxidectin And Ivermectin In Subjects With Onchocerca Volvulus Infection

Completed·MMedicines Development for Global Health·Phase 3·NCT00790998·1,497 enrolled

Ivermectin Therapy for Scabies Infection in Children Younger Than 5 Years of Age (ITCHY Study)

Active, not recruiting·MMurdoch Childrens Research Institute·Phase 2·NCT05500326·120 enrolled

Scabies2 trials

Veron Scabies Education and Eradication Program

Completed·—·N/A·NCT00604084·1,057 enrolled

Ivermectin/ Permethrin for Scabies

Completed·UUniversitas Padjadjaran·Phase 4·NCT05819983·60 enrolled

Safety and Efficacy2 trials

Safety and Efficacy of Drug Combinations Against Trichuris Trichiura

Completed·DDBL -Institute for Health Research and Development·N/A·NCT01050452·750 enrolled

Study Comparing the Safety and Efficacy of 0.5% Ivermectin Cream to Placebo in Lice Infested Subjects

Completed·TTopaz Pharmaceuticals Inc·Phase 2·NCT00994422·264 enrolled

Pneumonia1 trial

Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia

Recruiting·UUMC Utrecht·Phase 3·NCT02735707·20,000 enrolled

TED1 trial

Ivermectin Solution Bioequivalence Study - Fasted

Completed·JJohnson & Johnson Consumer and Personal Products Worldwide·Phase 1·NCT00921154·24 enrolled

Breast Cancer1 trial

Ivermectin in Combination With Balstilimab or Pembrolizumab in Patients With Metastatic Triple Negative Breast Cancer

Recruiting·YYuan Yuan·Phase 1/2·NCT05318469·34 enrolled

Drug Therapy1 trial

Eval 3-Drug Therapy Diethylcarbamize, Albendazole and Ivermectin That Could Accelerate LF Elimination Outside of Africa

Completed·UUniversity Hospitals Cleveland Medical Center·Phase 2·NCT01975441·182 enrolled

CLE1 trial

Effect of Albendazole Dose on Clearance of Filarial Worms

Completed·NNational Institute of Allergy and Infectious Diseases (NIAID)·Phase 2·NCT00339417·1,000 enrolled

Resistance1 trial

Insecticide Resistance Management in Burkina Faso and Côte D'Ivoire

Completed·IInstitut de Recherche pour le Developpement·Phase 3·NCT03074435·15,776 enrolled

Survival1 trial

Effect of Ivermectin Metabolites on Mosquito Survival

Completed·UUniversity of Oxford·Phase 4·NCT03690453·20 enrolled

Severe Acute Respiratory Syndrome1 trial

Prevention and Treatment for COVID -19 (Severe Acute Respiratory Syndrome Coronavirus 2 SARS-CoV-2) Associated Severe Pneumonia in the Gambia

Unknown status·LLondon School of Hygiene and Tropical Medicine·Phase 3·NCT04703608·1,200 enrolled

Pediatric Patients1 trial

Albendazole Plus High Dose Ivermectin for Trichuriasis in Pediatric Patients

Completed·AAlejandro Krolewiecki·Phase 2·NCT04041453·176 enrolled

Adverse Effect1 trial

Adverse Effects of Ivermectin Used in Egypt During COVID-19

Unknown status·MMenoufia University··NCT04747678·200 enrolled

Viral Infection1 trial

Oral Ivermectin for Chikungunya Viral Infection

Completed·PPrince of Songkla University·Phase 3·NCT06259383·120 enrolled

Immunity1 trial

Ivermectin and Human Immunity

Completed·UUniversity of Georgia·Phase 1·NCT03459794·12 enrolled

Acute Lymphoblastic Leukemia1 trial

Physiologically-based Pharmacokinetic Modeling of Ivermectin in Healthy Human Volunteers

Completed·UUniversity Hospital, Basel, Switzerland·Phase 1·NCT02963324·12 enrolled

Pediatric1 trial

Pharmacokinetics and Pharmacodynamics of Ivermectin in Pediatric Dengue Patients

Completed·MMahidol University·Phase 2·NCT03432442·24 enrolled

Skin Disease1 trial

Azithromycin - Ivermectin Mass Drug Administration for Skin Disease

Completed·LLondon School of Hygiene and Tropical Medicine·Phase 4·NCT02775617·1,291 enrolled

Clinical Trial1 trial

Clinical Trial to "Study the Efficacy and Therapeutic Safety of Ivermectin: (SAINTBO)

Unknown status·—·Phase 2·NCT04836299·90 enrolled

Pilot Study1 trial

Max Ivermectin- COVID 19 Study Versus Standard of Care Treatment for COVID 19 Cases. A Pilot Study

Unknown status·MMax Healthcare Insititute Limited·N/A·NCT04373824·50 enrolled

SARS-CoV-21 trial

Efficacy, Safety and Tolerability of Ivermectin in Subjects Infected With SARS-CoV-2 With or Without Symptoms

Completed·IInvestigacion Biomedica para el Desarrollo de Farmacos S.A. de C.V.·Phase 2·NCT04407507·66 enrolled

Cutaneous Warts1 trial

the Efficacy of Ivermectin Alone or With Microneedling in Treatment of Cutaneous Warts.

Not yet recruiting·—·Phase 1·NCT07396714·88 enrolled

Azithromycin1 trial

PK PD Study of IDA and Azithromycin for NTDs ( ComboNTDs )

Completed·LLihir Medical Centre·Phase 2·NCT03664063·42 enrolled

Alcohol Use Disorders1 trial

Development of Ivermectin for Alcohol Use Disorders

Completed·UUniversity of California, Los Angeles·Phase 1/2·NCT02046200·11 enrolled

Acceptability1 trial

Efficacy, Safety and Acceptability of Ivermectin ODT in PSAC

Completed·JJennifer Keiser·Phase 2·NCT06184399·260 enrolled

Lice Infestation1 trial

A Safety and Efficacy Study Comparing 0.5% Ivermectin Cream to a Vehicle Control in Subjects With Head Lice Infestation

Completed·TTopaz Pharmaceuticals Inc·Phase 3·NCT01066585·410 enrolled

Cohort Study1 trial

SARS-CoV-2 Pre-exposure Prophylaxis With Ivermectin Retrospective Cohort Study

Completed·GGrupo Rescue S.A.S República Dominicana··NCT04832945·713 enrolled

Effectiveness1 trial

Comparison Effectiveness of Oral Ivermectin , 1% Permethrin Shampoo and 4% Dimeticone Liquid Gel in the Treatment of Pediculosis Capitis Among School Children in Chachoengsao Province, Thailand

Active, not recruiting·PPhramongkutklao College of Medicine and Hospital·Phase 4·NCT06332872·117 enrolled

Fasting Conditions1 trial

Bioequivalence Study to Compare Two Tablets of Ivermectin Tablets (3 mg Ivermectin) Versus Two Tablets of Stromectol ® Tablets (3 mg Ivermectin), in Healthy Subjects Under Fasting Conditions

Completed·HHumanis Saglık Anonim Sirketi·Phase 1·NCT05082753·50 enrolled

GAN1 trial

Co-administration of IVM and ALB in School-based Deworming in Uganda

Completed·JJennifer Keiser··NCT06497075·8,767 enrolled

Unspecified5 trials

Ivermectina Colombia (IVERCOL)

Unknown status·AAyudas Diagnosticas Sura S.A.S·Phase 2/3·NCT04886362·966 enrolled

Moxidectin for LF, Cote d'Ivoire (DOLF)

Completed·WWashington University School of Medicine·Phase 3·NCT04410406·164 enrolled

Ivermectin Solution Bioequivalence Study - With Food

Completed·JJohnson & Johnson Consumer and Personal Products Worldwide·Phase 1·NCT00921674·24 enrolled

Show 2 more trials

Ivermectin Solution Bioequivalence Study - With Food (Repeat)

Completed·JJohnson & Johnson Consumer and Personal Products Worldwide·Phase 1·NCT00921219·34 enrolled

Bioequivalence Study of Ivermectin 1% Cream and Soolantra (Ivermectin) 10 mg/g Cream

Completed·HHumanis Saglık Anonim Sirketi·Phase 1·NCT06557603·44 enrolled

Regulatory

FDA Approval Timeline[5]

Oct 8, 1998

STROMECTOL

NDA NDA050742

Feb 7, 2012

SKLICE

NDA NDA202736

Dec 19, 2014

SOOLANTRA

NDA NDA206255

Sources

References

[1]
ClinicalTrials.gov — 135 trial records for Ivermectin. U.S. National Library of Medicine, National Institutes of Health.
[2]
MedlinePlus Drug Information — Stromectol drug information. U.S. National Library of Medicine, National Institutes of Health.
[3]
ChEMBL — Ivermectin compound record. European Bioinformatics Institute (EMBL-EBI).
[4]
Open Targets Platform — Drug–disease associations for Ivermectin. EMBL-EBI & Wellcome Sanger Institute.
[5]
OpenFDA — FDA approval records (NDA NDA206255). U.S. Food & Drug Administration.
[6]
FDA Orange Book — Patent and exclusivity data for Stromectol. U.S. Food & Drug Administration.
[7]
SEC EDGAR — Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Mechanism of Action: Glutamate-Gated Chloride Channel Modulator[3]
Modality: Small molecule[3]
Highest Phase: Approved[1]
Company: CCidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

Patent Landscape[6]

Patent Cliff

Mar 13, 2034

Earliest patent expiration — generic entry possible after this date

Patent #Expires

9233118Mar 13, 2034

9089587Mar 13, 2034

9233117Mar 13, 2034

9782425Mar 13, 2034

10206939Mar 13, 2034

Stromectol

Status by Indication[4][1]

Competitive Landscape

Expected Milestones

Q4 2026

Q1 2027

Q2 2027

Q3 2027

Trials by Indication[1]

COVID-1955 trials

Treatment11 trials

Malaria7 trials

Onchocerciasis7 trials

Rosacea4 trials

Efficacy and Safety3 trials

Children2 trials

Loiasis2 trials

Lymphatic Filariasis2 trials

Efficacy2 trials

Strongyloidiasis2 trials

Infection2 trials

Scabies2 trials

Safety and Efficacy2 trials

Pneumonia1 trial

TED1 trial

Breast Cancer1 trial

Drug Therapy1 trial

CLE1 trial

Resistance1 trial

Survival1 trial

Severe Acute Respiratory Syndrome1 trial

Pediatric Patients1 trial

Adverse Effect1 trial

Viral Infection1 trial

Immunity1 trial

Acute Lymphoblastic Leukemia1 trial

Pediatric1 trial

Skin Disease1 trial

Clinical Trial1 trial

Pilot Study1 trial

SARS-CoV-21 trial

Cutaneous Warts1 trial

Azithromycin1 trial

Alcohol Use Disorders1 trial

Acceptability1 trial

Lice Infestation1 trial

Cohort Study1 trial

Effectiveness1 trial

Fasting Conditions1 trial

GAN1 trial

Unspecified5 trials

FDA Approval Timeline[5]

References

Drug Info

Quick Facts

Patent Landscape[6]

Related News